Mitotic gene regulation by the N-MYC-WDR5-PDPK1 nexus

Sarah A Streeter1, Alexandria G Williams1, James R Evans1

  • 1Department of Biology, Middle Tennessee State University, Murfreesboro, TN, 37132, USA.

BMC Genomics
|April 11, 2024
PubMed
Abstract

Insights

MYC oncogene overexpression impairs mitosis. This study reveals a shared regulatory role for N-MYC, WDR5, and PDPK1 in controlling mitotic genes in neuroblastoma, suggesting a tripartite interaction.

Area of Science:

  • Cell Biology
  • Genomics
  • Cancer Research

Background:

  • Mitosis requires precise chromosome attachment and segregation for cell division.
  • MYC oncogene dysregulation in cancer leads to genomic instability.
  • WDR5, a MYC cofactor, interacts with PDPK1 to regulate mitotic genes.

Purpose of the Study:

  • To investigate the influence of WDR5 and PDPK1 on mitotic gene expression in MYC-overexpressing cancers.
  • To characterize the regulatory network involving N-MYC, WDR5, and PDPK1 in neuroblastoma.

Main Methods:

  • Comparative transcriptomic analysis using RNA-seq.
  • Engineered neuroblastoma cell lines (CHP-134) with MYCN-amplification.
  • Comparison with existing gene expression data after WDR5 inhibition.

Main Results:

  • N-MYC, PDPK1, and WDR5 commonly regulate a subset of genes involved in spindle pole formation and chromosome segregation.
  • PDPK1 regulates genes in development, signaling, and mitosis.
  • N-MYC interacts with PDPK1, mediated by WDR5, suggesting a regulatory nexus.

Conclusions:

  • A tripartite interaction among N-MYC, WDR5, and PDPK1 regulates mitotic genes in N-MYC amplified neuroblastoma.
  • This interaction is crucial for controlling mitotic gene expression levels.
  • Further studies are needed to elucidate the precise mechanism of this convergence.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K